Cardiac biomarkers play a pivotal role in modern healthcare, providing valuable insights into the functioning of the heart and aiding in the diagnosis, prognosis, and monitoring of cardiovascular conditions. These biomarkers, often proteins released into the bloodstream in response to heart damage or stress, serve as crucial indicators for healthcare professionals. Troponins, creatine kinase-MB (CK-MB), and B-type natriuretic peptide (BNP) are among the well-known cardiac biomarkers. The detection and analysis of these biomarkers have significantly enhanced our ability to assess cardiac health, allowing for early intervention and personalized treatment strategies. As the field of cardiac biomarkers continues to evolve, ongoing research explores novel markers and advanced diagnostic technologies, promising further advancements in cardiovascular care. The comprehensive understanding of cardiac biomarkers contributes to more accurate diagnoses, improved patient outcomes, and a deeper comprehension of heart-related diseases.
Title : Historical evolution from OPCAB to MIDCAB to mini OPCAB surgical technique and results
Federico Benetti, Benetti Foundation, Argentina
Title : Novel mechanisms and new therapeutics for right heart failure in pulmonary hypertension
Yong Xiao Wang, Albany Medical College, United States
Title : Movement is medicine
Steve Cohen, Medvesta Hypnosis Healthcare, United States
Title : Fats of life, the skinny on novel lipid therapies beyond statins
Ahdy Wadie Helmy, Indiana University School of Medicine, United States
Title : Novel ways of cardiovascular risk assessment
Syed Raza, Awali Hospital, Bahrain
Title : Analysis of cardiovascular risk factors in patients with type 1 diabetes mellitus
Mekhman N Mamedov, National Research Center for Preventive Medicine, Russian Federation